肿瘤细胞治疗研究
ALL SOURCES
Inhibition of osteosarcoma lung metastases by β-glucan and CD40 agonist is mediated by activation of macrophages and NK cells.
我们的研究结果表明β-葡聚糖对OS肺肿瘤负荷具有抗肿瘤活性，β-葡聚糖与CD40a联合使用可增强治疗活性，且该活性由先天免疫（巨噬细胞和NK细胞）的激活所介导。
Go to the scene: T(H)9 cells superior migration ability to the lungs explains their exceptional anticancer efficacy.
过去13年的这些发现支持了TH9细胞在癌症过继治疗中的临床评估。
COPS6 promotes tumor progression and reduces CD8(+) T cell infiltration by repressing IL-6 production to facilitate tumor immune evasion in breast can
我们得出结论，COPS6通过调节IL-6分泌，减少CD8+ T细胞浸润和功能，从而促进乳腺癌进展。
RREB1 could act as an immunological and prognostic biomarker: From comprehensive analysis to osteosarcoma validation.
RREB1显示出作为某些癌症预后标志物的潜力，并可能预测免疫治疗的疗效。此外，RREB1表达与免疫相关标志物相关，表明其在特定肿瘤的预后和预测免疫微环境治疗反应中发挥作用。
共 4 条
MEMBER ACCOUNT
登录成功会直接打开下一页。
